J.P. Marvel Investment Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-67,747
| Closed | -$4.26M | – | 70 |
|
|
2024
Q3 | $4.26M | Sell |
67,747
-1,445
| -2% | -$84.3K | 0.7% | 38 |
|
|
2024
Q2 | $4.09M | Sell |
69,192
-1,500
| -2% | -$93.8K | 0.67% | 40 |
|
|
2024
Q1 | $5.64M | Buy |
70,692
+2,728
| +4% | +$208K | 0.98% | 26 |
|
|
2023
Q4 | $5.37M | Buy |
67,964
+11,740
| +21% | +$836K | 1.06% | 28 |
|
|
2023
Q3 | $3.93M | Sell |
56,224
-3,170
| -5% | -$225K | 0.85% | 34 |
|
|
2023
Q2 | $4.11M | Sell |
59,394
-937
| -2% | -$66.7K | 0.86% | 34 |
|
|
2023
Q1 | $4.48M | Sell |
60,331
-61,121
| -50% | -$5.13M | 1.01% | 32 |
|
|
2022
Q4 | $11.3M | Sell |
121,452
-20
| -0% | -$1.93K | 2.66% | 14 |
|
|
2022
Q3 | $11.6M | Sell |
121,472
-155
| -0.1% | -$15.3K | 2.95% | 9 |
|
|
2022
Q2 | $11.3M | Hold |
121,627
| – | – | 2.71% | 15 |
|
|
2022
Q1 | $12.3M | Buy |
121,627
+186
| +0.2% | +$19.5K | 2.51% | 13 |
|
|
2021
Q4 | $12.5M | Buy |
121,441
+1,545
| +1% | +$143K | 2.45% | 13 |
|
|
2021
Q3 | $10.2M | Buy |
119,896
+33
| +0% | +$2.76K | 3.06% | 12 |
|
|
2021
Q2 | $10M | Buy |
119,863
+734
| +0.6% | +$60.1K | 2.13% | 20 |
|
|
2021
Q1 | $8.96M | Buy |
119,129
+13,134
| +12% | +$957K | 2.12% | 19 |
|
|
2020
Q4 | $7.24M | Buy |
105,995
+2,915
| +3% | +$190K | 1.87% | 24 |
|
|
2020
Q3 | $6.02M | Hold |
103,080
| – | – | 1.73% | 24 |
|
|
2020
Q2 | $6.7M | Buy |
103,080
+510
| +0.5% | +$32.1K | 2.12% | 17 |
|
|
2020
Q1 | $6.08M | Buy |
102,570
+39,215
| +62% | +$2.62M | 2.31% | 15 |
|
|
2019
Q4 | $4.71M | Buy |
63,355
+9,593
| +18% | +$674K | 1.36% | 36 |
|
|
2019
Q3 | $3.39M | Buy |
+53,762
| New | +$3.19M | 1.09% | 37 |
|
|
2016
Q2 | – | Sell |
-48,090
| Closed | -$4.99M | – | 83 |
|
|
2016
Q1 | $4.99M | Hold |
48,090
| – | – | 1.8% | 23 |
|
|
2015
Q4 | $4.7M | Buy |
+48,090
| New | +$4.71M | 1.64% | 26 |
|
|
2015
Q2 | $5.16M | Sell |
49,225
-1,000
| -2% | -$102K | 1.74% | 23 |
|
|
2015
Q1 | $5.18M | Buy |
50,225
+820
| +2% | +$83K | 1.77% | 22 |
|
|
2014
Q4 | $4.76M | Sell |
49,405
-95
| -0.2% | -$8.37K | 1.65% | 22 |
|
|
2014
Q3 | $3.94M | Sell |
49,500
-260
| -0.5% | -$20.5K | 1.43% | 30 |
|
|
2014
Q2 | $3.75M | Sell |
49,760
-500
| -1% | -$37.8K | 1.28% | 34 |
|
|
2014
Q1 | $3.76M | Sell |
50,260
-50
| -0.1% | -$3.53K | 1.33% | 31 |
|
|
2013
Q4 | $3.6M | Sell |
50,310
-1,880
| -4% | -$121K | 1.29% | 33 |
|
|
2013
Q3 | $2.96M | Sell |
52,190
-330
| -0.6% | -$19.7K | 1.15% | 37 |
|
|
2013
Q2 | $3M | Buy |
+52,520
| New | +$3.04M | 1.25% | 38 |
|
Other funds holding CVS
J.P. Marvel Investment Advisors's CVS Position: Q4 2024 in Review
J.P. Marvel Investment Advisors sold out of CVS Health (CVS) in Q4 2024, closing a stake of 67,747 shares — an estimated $4.26M sold.
J.P. Marvel Investment Advisors first reported a position in CVS in Q2 2013 and held it in 32 quarters. The position peaked at $12.5M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- J.P. Marvel Investment Advisors reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
- J.P. Marvel Investment Advisors sold 67,747 CVS Health shares in Q4 2024, an estimated $4.26M.
- J.P. Marvel Investment Advisors first reported a position in CVS Health in Q2 2013 and held it in 32 quarters.
- J.P. Marvel Investment Advisors's CVS Health position peaked at $12.5M in Q4 2021.
- 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on J.P. Marvel Investment Advisors's 13F filing for Q4 2024, filed 30 Jan 2025.